injektions-/infusionsvæske
Sponsors
Rigshospitalet, Hvidovre Hospital, Astellas Pharma Global Development Inc.
Conditions
Following heart surgeryLocally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaLung cancerPatients resuscitated from out-of-hospital cardiac arrestStaphylococcus aureus bacteremiaWe investigate the efficacy of two pharmaceutical interventions for reducing mortality and organ damageand shortening length of hospital stay in patients undergoing heart surgery (i.e. coronary artery bypass
grafting and/or heart valve replacement).patients experience poor postoperative pain control and a moderate/high opioid consumptions. This is correlated to
adverese events and poor outcome.
Phase 2
Phase 3
DANOHCA: The Danish Out-of-Hospital Cardiac Arrest study
RecruitingCTIS2024-515997-28-00
Start: 2023-06-16Target: 1000Updated: 2025-12-05
GLORIOUS II: Dexamethasone, olanzapine, flow-targeted versus pressure-targeted hemodynamic management, and low tidal volume ventilation in patients undergoing on-pump cardiac surgery – a multifactorial design randomized trial
RecruitingCTIS2024-515998-94-00
Start: 2022-11-10Target: 1200Updated: 2024-10-23
A Phase 3, Global, Multi-center, Double-blind, Randomized Study of ASP2138 plus Chemotherapy (CAPOX or mFOLFOX6) with Pembrolizumab vs Placebo plus Chemotherapy with or without Pembrolizumab in First-line Treatment of Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma in Participants Whose Tumors Are HER2-negative and Claudin (CLDN) 18.2-positive
Not yet recruitingCTIS2025-524557-14-00
Target: 96Updated: 2026-10-23
Phase 4
Methadone versus fentanil and oxycodone for post-operative pain reduction in patients undergoing coronary artery bypass grafting and/or valve surgery –
a placebo-controlled, double-blind, randomized clinical trial
Not yet recruitingCTIS2024-519224-24-00
Target: 220Updated: 2025-01-10
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia:
A randomized, non-blinded, non-inferiority interventional study
RecruitingCTIS2024-519186-21-01
Start: 2025-01-30Target: 264Updated: 2025-11-17